Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metabolites related to purine catabolism and risk of type 2 diabetes incidence, modifying effects of the TCF7L2-rs7903146 polymorphism

  • Papandreou, Christopher|||0000-0002-6803-507X
  • Li, Jun
  • Liang, Liming|||0000-0001-8261-3174
  • Bulló, Mònica|||0000-0002-0218-7046
  • Zheng, Yan
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Yu, Edward
  • Guasch-Ferré, Marta
  • Razquín, Cristina|||0000-0003-3480-2645
  • Clish, Clary|||0000-0001-8259-9245
  • Corella, Dolores|||0000-0002-2366-4104
  • Estruch, Ramón|||0000-0003-1260-4445
  • Ros, Emilio|||0000-0002-2573-1294
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Arós, Fernando
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Rosique, Nuria
  • Martínez-González, Miguel A.
  • Hu, Frank B..
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Studies examining associations between purine metabolites and type 2 diabetes (T2D) are limited. We prospectively examined associations between plasma levels of purine metabolites with T2D risk and the modifying effects of transcription factor-7-like-2 (TCF7L2) rs7903146 polymorphism on these associations. This is a case-cohort design study within the PREDIMED study, with 251 incident T2D cases and a random sample of 694 participants (641 non-cases and 53 overlapping cases) without T2D at baseline (median follow-up: 3.8 years). Metabolites were semi-quantitatively profiled with LC-MS/MS. Cox regression analysis revealed that high plasma allantoin levels, including allantoin-to-uric acid ratio and high xanthine-to-hypoxanthine ratio were inversely and positively associated with T2D risk, respectively, independently of classical risk factors. Elevated plasma xanthine and inosine levels were associated with a higher T2D risk in homozygous carriers of the TCF7L2-rs7903146 T-allele. The potential mechanisms linking the aforementioned purine metabolites and T2D risk must be also further investigated.